These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 9641189

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA, McParland C, Keogh JA.
    Nephrol Dial Transplant; 1987; 2(2):117-9. PubMed ID: 3112649
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Desferrioxamine infusion can modify EEG tracing in haemodialysed patients.
    Brancaccio D, Avanzini G, Padovese P, Gallieni M, Franceschetti S, Panzica F, Anelli A, Colantonio G, Martinelli D, Bugiani O.
    Nephrol Dial Transplant; 1991; 6(4):264-8. PubMed ID: 1881580
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Detecting and evaluating hyperaluminemia in 3 dialysis centers].
    Balabán D, Simícková J, Kubátko J, Syrovátka P.
    Cas Lek Cesk; 1989 Dec 15; 128(51):1611-4. PubMed ID: 2631999
    [Abstract] [Full Text] [Related]

  • 27. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
    Charhon SA, Chavassieux P, Chapuy MC, Accominotti M, Traeger J, Meunier PJ.
    Presse Med; 1986 Jan 18; 15(2):55-9. PubMed ID: 2935857
    [Abstract] [Full Text] [Related]

  • 28. Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration.
    Menéndez-Fraga P, Fernández-Martín JL, Blanco-González E, Cannata-Andía JB.
    Clin Chem; 1998 Jun 18; 44(6 Pt 1):1262-8. PubMed ID: 9625051
    [Abstract] [Full Text] [Related]

  • 29. Low-dose desferrioxamine test for the diagnosis of aluminium-related bone disease in patients on regular haemodialysis.
    Yaqoob M, Ahmad R, Roberts N, Helliwell T.
    Nephrol Dial Transplant; 1991 Jun 18; 6(7):484-6. PubMed ID: 1922909
    [Abstract] [Full Text] [Related]

  • 30. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 31. Predictive value of desferrioxamine infusion test for bone aluminium deposits in hemodialyzed patients.
    Berland Y, Charhon SA, Olmer M, Meunier PJ.
    Nephron; 1985 Jun 14; 40(4):433-5. PubMed ID: 4022212
    [Abstract] [Full Text] [Related]

  • 32. Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.
    Van Landeghem GF, D'Haese PC, Lamberts LV, Barata JD, De Broe ME.
    Nephrol Dial Transplant; 1997 Aug 14; 12(8):1692-8. PubMed ID: 9269651
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H, Stummvoll HK, Kovarik J, Meisinger V, Wolf A, Pinggera WF.
    Wien Klin Wochenschr; 1980 Aug 14; 92(11):391-4. PubMed ID: 7424016
    [Abstract] [Full Text] [Related]

  • 35. Aluminium interference in the treatment of haemodialysis patients with recombinant human erythropoietin.
    Casati S, Castelnovo C, Campise M, Ponticelli C.
    Nephrol Dial Transplant; 1990 Aug 14; 5(6):441-3. PubMed ID: 2122321
    [Abstract] [Full Text] [Related]

  • 36. Grand mal fitting in a patient on regular haemodialysis treatment and receiving desferrioxamine therapy.
    Davenport A, Ahmad R.
    Scand J Urol Nephrol; 1988 Aug 14; 22(2):159-60. PubMed ID: 3144735
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Verification of desferrioxamine ototoxicity by high-frequency audiometry in patients undergoing dialysis].
    Martín C, Lens XM, Prieto A, Alonso R, Correa B, Arcocha V, Soto A.
    An Otorrinolaringol Ibero Am; 1994 Aug 14; 21(2):193-8. PubMed ID: 8209972
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Silicon and aluminium interactions in haemodialysis patients.
    Parry R, Plowman D, Delves HT, Roberts NB, Birchall JD, Bellia JP, Davenport A, Ahmad R, Fahal I, Altmann P.
    Nephrol Dial Transplant; 1998 Jul 14; 13(7):1759-62. PubMed ID: 9681724
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.